Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 5,320.00
+320.00 (6.40%)
Oct 31, 2025, 1:40 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 230.23 billion as of October 30, 2025. Its market cap has increased by 43.88% in one year.
Market Cap
230.23B
Enterprise Value
148.31B
Revenue
4.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,320.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 230.23B, a decrease of -3.52%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 244.05B | 96.30% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | 882.29B | -55.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.90T |
| ALTEOGEN | 24.95T |
| SK Biopharmaceuticals | 8.97T |
| Yuhan | 8.77T |
| HLB Co., Ltd. | 6.30T |
| Peptron | 6.18T |
| PharmaResearch | 5.36T |